| Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers SA Wahajuddin International Journal of Nanomedicine 7, 3445, 2012 | 1122 | 2012 |
| Efficient Hepatic Delivery of Drugs: Novel Strategies and Their Significance SA Nidhi Mishra,1 Narayan Prasad Yadav,1 Vineet Kumar BioMed Research International, 2013 | 143 | 2013 |
| Advances in experimental and mechanistic computational models to understand pulmonary exposure to inhaled drugs P Bäckman, S Arora, W Couet, B Forbes, W de Kruijf, A Paudel European Journal of Pharmaceutical Sciences 113, 41-52, 2018 | 106 | 2018 |
| Disposition of Pharmacologically Active Dietary Isoflavones in Biological Systems. I Taneja, S Arora, KS Raju, N Siddiqui Current drug metabolism, 2013 | 44 | 2013 |
| Development of an inhaled controlled release voriconazole dry powder formulation for the treatment of respiratory fungal infection S Arora, M Haghi, CY Loo, D Traini, PM Young, S Jain Molecular pharmaceutics 12 (6), 2001-2009, 2015 | 41 | 2015 |
| On absorption modeling and food effect prediction of rivaroxaban, a BCS II drug orally administered as an immediate-release tablet V Kushwah, S Arora, M Tamás Katona, D Modhave, E Fröhlich, A Paudel Pharmaceutics 13 (2), 283, 2021 | 38 | 2021 |
| Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability DTSJ Sumit Arora, Mehra Haghi, Paul M. Young, Michael Kappl Expert Opinion on Drug Delivery, 2015 | 38* | 2015 |
| Use of PBPK Modeling To Evaluate the Performance of DissolvIt, a Biorelevant Dissolution Assay for Orally Inhaled Drug Products M Hassoun, M Malmlöf, O Scheibelhofer, A Kumar, S Bansal, E Selg, ... Molecular pharmaceutics 16 (3), 1245-1254, 2019 | 31 | 2019 |
| Physiologically based pharmacokinetic modeling of transdermal selegiline and its metabolites for the evaluation of disposition differences between healthy and special populations SK Puttrevu, S Arora, S Polak, NK Patel Pharmaceutics 12 (10), 942, 2020 | 30 | 2020 |
| Biopharmaceutic In Vitro In Vivo Extrapolation (IVIV_E) Informed Physiologically-Based Pharmacokinetic Model of Ritonavir Norvir Tablet Absorption in Humans … S Arora, A Pansari, P Kilford, M Jamei, I Gardner, DB Turner Molecular Pharmaceutics 17 (7), 2329-2344, 2020 | 27 | 2020 |
| Formulation, optimization, and in vitro–in vivo evaluation of olmesartan medoxomil nanocrystals S Jain, K Patel, S Arora, VA Reddy, CP Dora Drug delivery and translational research 7, 292-303, 2017 | 27 | 2017 |
| Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability S Jain, VA Reddy, S Arora, K Patel Drug delivery and translational research 6, 498-510, 2016 | 26 | 2016 |
| Biorelevant two-stage in vitro testing for rDCS classification and in PBPK modeling–case example ritonavir T Fiolka, J Van Den Abeele, P Augustijns, S Arora, J Dressman Journal of pharmaceutical sciences 109 (8), 2512-2526, 2020 | 24 | 2020 |
| Multi‐phase multi‐layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin N Patel, JF Clarke, F Salem, T Abdulla, F Martins, S Arora, E Tsakalozou, ... CPT: Pharmacometrics & Systems Pharmacology 11 (8), 1060-1084, 2022 | 22 | 2022 |
| Investigation of surface properties, local elastic modulus and interaction with simulated pulmonary surfactant of surface modified inhalable voriconazole dry powders using … S Arora, M Kappl, M Haghi, MP Young, D Traini, S Jain RSC Advances, 2016 | 16 | 2016 |
| Development of voriconazole loaded large porous particles for inhalation delivery: Effect of surface forces on aerosolisation performance, assessment of in vitro safety … S Arora, RR Mahajan, V Kushwah, D Baradia, A Misra, S Jain RSC Advances 5 (48), 38030-38043, 2015 | 16 | 2015 |
| Evaluating the impact of acid-reducing agents on drug absorption using biorelevant in vitro tools and PBPK modeling-case example dipyridamole D Segregur, R Barker, J Mann, A Moir, EM Karlsson, DB Turner, S Arora, ... European Journal of Pharmaceutical Sciences 160, 105750, 2021 | 12 | 2021 |
| Mechanistic modeling of in vitro skin permeation and extrapolation to in vivo for topically applied metronidazole drug products using a physiologically based pharmacokinetic model S Arora, J Clarke, E Tsakalozou, P Ghosh, K Alam, JE Grice, MS Roberts, ... Molecular Pharmaceutics 19 (9), 3139-3152, 2022 | 10 | 2022 |
| Isoflavones: Chemistry, Analysis, Function and Effects- Chapeter 14: High-throughput Quantification of Pharmacologically Active Isoflavones using LC-UV/PDA and LC-MS/MS W Sumit Arora Royal Society of Chemistry, 2013 | 8* | 2013 |
| A mechanistic absorption and disposition model of ritonavir to predict exposure and Drug–Drug interaction potential of CYP3A4/5 and CYP2D6 substrates S Arora, A Pansari, PJ Kilford, M Jamei, DB Turner, I Gardner European Journal of Drug Metabolism and Pharmacokinetics 47 (4), 483-495, 2022 | 7 | 2022 |
Sanyog JainCentre for Pharmaceutical Nanotechnology, Dept of Pharmaceutics, NIPEREmail verificata su niper.ac.in
